Review of the validated HPLC and LC-MS/MS methods for determination of drugs used in clinical practice for Alzheimer's disease

Biomedical Chromatography

Volumn 28, Issue 11, 2014, Pages 1431-1490

  Ponnayyan Sulochana, Suresh ^a   Sharma, Kuldeep ^b   Mullangi, Ramesh ^b   Sukumaran, Sathesh Kumar ^a  

^a VELS INSTITUTE OF SCIENCE   (India)

^b JUBILANT BIOSYS LTD   (India)

Author keywords

Alzheimer's drugs; Bioanalytical methods; Donepezil; Galantamine; HPLC; LC MS; Memantine; Review; Rivastigmine; Tacrine

Indexed keywords

DRUG DOSAGE; DRUG PRODUCTS; NEURODEGENERATIVE DISEASES;

ALZHEIMER; ALZHEIMER DRUG; BIOANALYTICAL METHODS; DONEPEZIL; GALANTAMINE; HPLC; LC-MS; MEMANTINE; RIVASTIGMINE; TACRINE;

MASS SPECTROMETRY;

DONEPEZIL; GALANTAMINE; MEMANTINE; RIVASTIGMINE; TACRINE; CARBAMIC ACID DERIVATIVE; CHOLINESTERASE INHIBITOR; INDAN DERIVATIVE; NEUROPROTECTIVE AGENT; NOOTROPIC AGENT; PIPERIDINE DERIVATIVE;

ALZHEIMER DISEASE; ARTICLE; CLINICAL PRACTICE; DRUG BLOOD LEVEL; DRUG DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; PRECIPITATION; QUANTITATIVE ANALYSIS; SOLID PHASE EXTRACTION; STANDARD; TANDEM MASS SPECTROMETRY; PROCEDURES;

ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GALANTAMINE; HUMANS; INDANS; NEUROPROTECTIVE AGENTS; NOOTROPIC AGENTS; PHENYLCARBAMATES; PIPERIDINES; TANDEM MASS SPECTROMETRY;

EID: 84911981780     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.3116     Document Type: Article

References (65)

1. Abonassif MA, Hefnawy MM, Kassem MG and Mostafa GA. Determination of donepezil hydrochloride in human plasma and pharmaceutical formulations by HPLC with fluorescence detection. Acta Pharmaceutica 2011; 61: 403-413.
2. Almeida AA, Campos DR, Bernasconi G, Calafatti S, Barros FA, Eberlin MN, Meurer EC, Paris EG and Pedrazzoli J. Determination of memantine in human plasma by liquid chromatography electrospray tandem mass spectrometry: application to a bioequivalence study. Journal of Chromatography B 2007; 848: 311-316.
3. Amatsubo T, Yanagisawa D, Morikawa S, Taguchi H and Tooyama I. Amyloid imaging using high-field magnetic resonance. Magnetic Resonance Medical Sciences 2010; 9: 95-99.
4. Amini H and Ahmadiani A. High performance liquid chromatographic determination of rivastigmine in human plasma for application in pharmacokinetic studies. Journal of Pharmaceutical Research 2010; 9: 115-121.
5. Apostolou C, Dotsikas Y, Kousoulos C and Loukas YL. Quantitative determination of donepezil in human plasma by liquid chromatography tandem mass spectrometry employing an automated liquid-liquid extraction based on 96-well format plates application to a bioequivalence study. Journal of Chromatography B 2007; 848: 239-244.
6. Arumugam K, Chamallamudi M, Mallayasamy S, Mullangi R, Ganesan S, Jamadar L, Ranjithkumar A and Udupa N. High performance liquid chromatographic fluorescence detection method for the quantification of rivastigmine in rat plasma and brain: application to preclinical pharmacokinetic studies in rats. Journal of Young Pharmacists 2011a; 3: 315-321.
7. Arumugam K, Chamallamudi MR, Gilibili RR, Mullangi R, Ganesan S, Kar SS, Averineni R, Shavi G and Udupa N. Development and validation of a HPLC method for quantification of rivastigmine in rat urine and identification of novel metabolite in urine by LC-MS/MS. Biomedical Chromatography 2011b; 25: 353-361.
8. Berchtold NC and Cotman CW. Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-roman period to the 1960s. Neurobiology of Aging 1998; 19: 173-189.
9. Bhatt J, Subbaiah G, Kambli S, Shah B, Nigam S, Patel M, Saxena A, Baliga A, Parekh H and Yadav G. A rapid and sensitive liquid chromatography tandem mass spectrometry (LC-MS/MS) method for the estimation of rivastigmine in human plasma. Journal of Chromatography B 2007; 852: 115-121.
10. Blennow K and Hampel H. CSF markers for incipient Alzheimer's disease. Lancet Neurology 2003; 2: 605-613.
11. Claessens HA, van Thiel M, Westra P and Soeterboek AM. High performance liquid chromatographic determination of galanthamine, a long acting anticholinesterase drug, in serum, urine and bile. Journal of Chromatography 1983; 275: 345-353.
12. Ekman L, Lindstrom B and Roxin P. Determination of tacrine and its 1-hydroxy metabolite in plasma using column liquid chromatography with ultraviolet detection. Journal of Chromatography 1989; 494: 397-402.
13. Enz A, Chappuis A and Dattler A. A simple, rapid and sensitive method for simultaneous determination of rivastigmine and its major metabolite NAP 226-90 in rat brain and plasma by reversed-phase liquid chromatography coupled to electrospray ionization mass spectrometry. Biomedical Chromatography 2004; 18: 160-166.
14. Farlow MR. NMDA receptor antagonists. A new therapeutic approach for Alzheimer's disease. Geriatrics 2004; 59: 22-27.
15. Forsyth DR, Ford JM, Truman CA, Roberts CJ and Wilcock GK. Determination of tacrine hydrochloride in human serum by chloroform extraction, reversed phase high performance liquid chromatography and fluorimetric detection. Journal of Chromatography 1988; 433: 352-358.
16. Francis PT, Palmer AM, Snape M and Wilcock GK. The cholinergic hypothesis of Alzheimer's disease: a review of progress. Journal of Neurology, Neurosurgery and Psychiatry 1999; 66: 137-147.
17. Frankfort SV, Ouwehand M, van Maanen MJ, Rosing H, Tulner LR and Beijnen JH. A simple and sensitive assay for the quantitative analysis of rivastigmine and its metabolite NAP 226-90 in human EDTA plasma using coupled liquid chromatography and tandem mass spectrometry. Rapid Communications in Mass Spectrometry 2006; 20: 3330-3336.
18. Haginaka J and Seyama C. Determination of enantiomers of 1-benzyl-4-[(5, 6-dimethoxy-1-indanon)-2-yl]methylpiperidine hydrochloride (E2020), a centrally acting acetylcholine esterase inhibitor, in plasma by liquid chromatography with fluorometric detection. Journal of Chromatography 1992; 577: 95-102.
19. Han J, Jiang S, Cui X, Sun Y, Li G, Zhang J, Fawcett JP and Gu J. Quantitation of the tacrine analogue octahydroaminoacridine in human plasma by liquid chromatography-tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 2009; 50: 171-174.
20. Hansen LL, Larsen JT and Brosen K. Determination of tacrine and its metabolites in human plasma and urine by high performance liquid chromatography and fluorescence detection. Journal of Chromatography B 1998; 712: 183-191.
21. 18 extraction. Journal of Chromatography 1983; 274: 388-392.
22. Hsu RS, Dileo EM and Chesson SM. High performance liquid chromatography for the determination of tacrine and its metabolites in plasma. Journal of Chromatography 1990; 530: 170-176.
23. Iordachescu A, Silvestro L, Tudoroniu A, Savu SR and Ciuca V. LC-MS-MS method for the simultaneous determination of donepezil enantiomers in plasma. Chromatographia 2012; 75: 857-866.
24. Karthik A, Subramanian GS, Surulivelrajan M, Ranjithkumar A and Kamat SB. Fluorimetric determination of rivastigmine in rat plasma by a reverse phase high performance liquid chromatographic method. Application to a pharmacokinetic study. Arzneimittelforschung 2008; 58: 205-210.
25. Khuroo AH, Gurule SJ, Monif T, Goswami D, Saha A and Singh SK. ESI-MS/MS stability-indicating bioanalytical method development and validation for simultaneous estimation of donepezil, 5-desmethyl donepezil and 6-desmethyl donepezil in human plasma. Biomedical Chromatography 2012; 26: 636-649.
26. Kim KA, Lim JL, Kim C and Park JY. Pharmacokinetic comparison of orally disintegrating and conventional donepezil formulations in healthy Korean male subjects: a single-dose, randomized, open-label, 2-sequence, 2-period crossover study. Clinical Therapeutics 2011; 33: 965-972.
27. Koeber R, Kluenemann HH, Waimer R, Koestlbacher A, Wittmann M, Brandl R, Doerfelt A, Jahner T, Melchner D and Haen E. Implementation of a cost-effective HPLC/UV-approach for medical routine quantification of donepezil in human serum. Journal of Chromatography B 2012; 881-882: 1-11.
28. Konda RK, Challa BR, Chandu BR and Chandrasekhar KB. Bioanalytical method development and validation of memantine in human plasma by high performance liquid chromatography with tandem mass spectrometry: application to bioequivalence study. Journal of Analytical Methods in Chemistry 2012; 2012: 101249.
29. Liu MY, Meng SN, Wu HZ, Wang S and Wei MJ. Pharmacokinetics of single-dose memantine in healthy Chinese volunteers using an analytic method of liquid chromatography tandem mass spectrometry. Clinical Therapeutics 2008; 30: 641-653.
30. Liu W, Bi K, Liu X, Zhao J and Chen X. Cloud-point extraction combined with LC-MS for analysis of memantine in rat plasma. Chromatographia 2009; 69: 837-842.
31. Lu Y, Wen H, Li W, Chi Y and Zhang Z. Determination of donepezil hydrochloride (E2020) in plasma by liquid chromatography mass spectrometry and its application to pharmacokinetic studies in healthy, young, Chinese subjects. Journal of Chromatographic Science 2004; 42: 234-237.
32. Malakova J, Nobilis M, Svoboda Z, Lisa M, Holcapek M, Kvetina J, Klimes J and Palicka V. High performance liquid chromatographic method with UV photodiode array, fluorescence and mass spectrometric detection for simultaneous determination of galantamine and its phase I metabolites in biological samples. Journal of Chromatography B 2007; 853: 265-274.
33. Matsui K, Oda Y, Ohe H, Tanaka S and Asakawa N. Direct determination of E2020 enantiomers in plasma by liquid chromatography-mass spectrometry and column-switching techniques. Journal of Chromatography A 1995; 694: 209-218.
34. Matsui K, Oda Y, Nakata H and Yoshimura T. Simultaneous determination of donepezil (Aricept) enantiomers in human plasma by liquid chromatography-electrospray tandem mass spectrometry. Journal of Chromatography B 1999; 729: 147-155.
35. Meier-Davis SR, Meng M, Yuan W, Diehl L, Arjmand FM, Lucke RM, Huang B, Wen J, Shudo J and Nagata T. Dried blood spot analysis of donepezil in support of a GLP3-month dose-range finding study in rats. International Journal of Toxicology 2012; 31: 337-347.
36. Nakashima K, Itoh K, Kono M, Nakashima MN and Wada M. Determination of donepezil hydrochloride in human and rat plasma, blood and brain microdialysates by HPLC with a short C30 column. Journal of Pharmaceutical and Biomedical Analysis 2006: 41: 201-206.
37. Nirogi RV, Kandikere VN, Mudigonda K and Maurya S. Quantitative determination of galantamine in human plasma by sensitive liquid chromatography-tandem mass spectrometry using loratadine as an internal standard. Journal of Chromatography Science 2007; 45: 97-103.
38. Noetzli M, Choong E, Ansermot N and Eap CB. Simultaneous determination of antidementia drugs in human plasma for therapeutic drug monitoring. Therapeutic Drug Monitoring 2011; 33: 227-238.
39. Noetzli M, Ansermot N, Dobrinas M and Eap CB. Simultaneous determination of antidementia drugs in human plasma: procedure transfer from HPLC-MS to UPLC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis 2012; 64-65: 16-25.
40. Pan RN, Chian TY, Kuo BPC and Pao LH. Determination of memantine in human plasma by LC-MS-MS. Application to a pharmacokinetic study. Chromatographia 2009; 70: 783-788.
41. Park EJ, Lee HW, Ji HY, Kim HY, Lee MH, Park ES, Lee KC and Lee HS. Hydrophilic interaction chromatography-tandem mass spectrometry of donepezil in human plasma: application to a pharmacokinetic study of donepezil in volunteers. Archives in Pharmaceutical Research 2008; 31: 1205-1211.
42. Park YS, Kim SH, Kim SY, Kim YH, Lee MH, Yang SC, Shaw LM and Kang JS. Quantification of galantamine in human plasma by validated liquid chromatography-tandem mass spectrometry using glimepiride as an internal standard: application to bioavailability studies in 32 healthy Korean subjects. Journal of Chromatographic Science 2012; 50: 803-809.
43. Patel BN, Sharma N, Sanyal M and Shrivastav PS. Quantitation of donepezil and its active metabolite 6-O-desmethyl donepezil in human plasma by a selective and sensitive liquid chromatography-tandem mass spectrometric method. Analytica Chimica Acta 2008; 629: 145-157.
44. Pilli NR, Inamadugu JK, Kondareddy N, Karra VK, Damaramadugu R and Rao JV. A rapid and sensitive LC-MS/MS method for quantification of donepezil and its active metabolite, 6-O-desmethyl donepezil in human plasma and its pharmacokinetic application. Biomedical Chromatography 2011; 25: 943-951.
45. Pohanka M. Cholinesterases, a target of pharmacology and toxicology. Biomed Papers of the Medical Faculty of the University Palacky Olomouc, Czechoslovakia Republic 2011; 155: 219-229.
46. Pommier F and Frigola R. Quantitative determination of rivastigmine and its major metabolite in human plasma by liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry. Journal of Chromatography B 2003; 784: 301-313.
47. Puente B, Hernandez E, Perez S, Pablo L, Prieto E, Garcia MA and Bregante MA. Determination of memantine in plasma and vitreous humour by HPLC with precolumn derivatization and fluorescence detection. Journal of Chromatography Science 2011; 49: 745-752.
48. Radwan MA, Abdine HH, Al-Quadeb BT, Aboul-Enein HY and Nakashima K. Stereoselective HPLC assay of donepezil enantiomers with UV detection and its application to pharmacokinetics in rats. Journal of Chromatography B 2006; 830: 114-119.
49. Raschetti R, Albanese E, Vanacore N and Maggini M. Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials. PLoS Medicine 2007; 4: e338.
50. Shah HJ, Kundlik ML, Pandya A, Prajapati S, Subbaiah G, Patel CN, Patel DM and Suhagia BN. A rapid and specific approach for direct measurement of donepezil concentration in human plasma by LC-MS/MS employing solid-phase extraction. Biomedical Chromatography 2009; 23: 141-151.
51. Shuangjin C, Fang F, Han L and Ming M. New method for high-performance liquid chromatographic determination of amantadine and its analogues in rat plasma. Journal of Pharmaceutical and Biomedical Analysis 2007; 44: 1100-1105.
52. Steiner WE, Pikalov IA, Williams PT, English EA and Hilmas CJ. Development of a Novel LC/MS/MS extraction assay for galanthamine in guinea pig plasma and its application to nerve agent countermeasures. Open Access Scient. Rep. 2012; 1: scientific report 149.
53. Suckow RF, Zhang MF, Collins ED, Fischman MW and Cooper TB. Sensitive and selective liquid chromatographic assay of memantine in plasma with fluorescence detection after pre-column derivatization. Journal of Chromatography B 1999; 29: 217-224.
54. Tencheva J, Yamboliev I and Zhivkova Z. Reversed-phase liquid chromatography for the determination of galanthamine and its metabolites in human plasma and urine. Journal of Chromatography 1987; 421: 396-400.
55. Thevis M, Wilkens F, Geyer H and Schanzer W. Determination of therapeutics with growth hormone secretagogue activity in human urine for doping control purposes. Rapid Communications in Mass Spectrometry 2006; 20: 3393-3402.
56. Verhaeghe T, Diels L, de Vries R, De Meulder M and de Jong J. Development and validation of a liquid chromatographic-tandem mass spectrometric method for the determination of galantamine in human heparinised plasma. Journal of Chromatography B 2003; 789: 337-346.
57. Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M, Scheltens P, Tariska P and Winblad B. Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. European Journal of Neurology 2007; 14: e1-26.
58. Wang JM and Sun C. Calcium and neurogenesis in Alzheimer's disease. Frontiers in Neuroscience 2010; 4: 194.
59. Xie MF, Zhou W, Tong XY, Chen YL, Cai Y, Li Y and Duan GL. High-performance liquid chromatographic determination of memantine hydrochloride in rat plasma using sensitive fluorometric derivatization. Journal of Separation Sciences 2011; 34: 241-246.
60. Xie Z, Liao Q, Xu X, Yao M, Wan J and Liu D. Rapid and sensitive determination of donepezil in human plasma by liquid chromatography/tandem mass spectrometry: application to a pharmacokinetic study. Rapid Communications in Mass Spectrometry 2006; 20: 3193-3198.
61. Yasui-Furukori N, Furuya R, Takahat T and Tateishi T. Determination of donepezil, an acetylcholinesterase inhibitor, in human plasma by high-performance liquid chromatography with ultraviolet absorbance detection. Journal of Chromatography B 2002; 768: 261-265.
62. Yu H, Li WM, Kan KK, Ho JM, Carlier PR, Pang YP, Gu ZM, Zhong Z, Chan K, Wang YT and Han YF. Development of a high performance liquid chromatography-tandem mass method for determination of bis(7)-tacrine, a promising anti-Alzheimer's dimer, in rat blood. Journal of Pharmaceutical and Biomedical Analysis 2007; 44: 1133-1138.
63. Zarghi A, Shafaati A, Foroutan SM, Khoddam A and Madadian B. Sensitive and rapid HPLC method for determination of memantine in human plasma using OPA derivatization and fluorescence detection: application to pharmacokinetic studies. Scientica Pharmaceutica 2010; 78: 847-856.
64. Zhang L, Yu H, Li WM, Cheung MC, Pang YP, Lin G, Wang YT, Zuo Z and Han YF. Selective and sensitive determination of bis(7)-tacrine, a high erythrocyte binding acetylcholinesterase inhibitor, in rat plasma by high-performance liquid chromatography-tandem mass spectrometry. Biomedical Chromatography 2008; 22: 414-420.
65. Zhang LJ, Fang XL, Li XN, Wang QS, Han LM, Zhang ZW and Sha XY. Pharmacokinetics and bioequivalence studies of galantamine hydrobromide dispersible tablet in healthy male Chinese volunteers. Drug Development and Industrial Pharmacy 2007; 33: 335-340.